These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 6352620

  • 21. An open study of the use of ceftazidime in Gram-negative infections.
    Wardle JK, Snow MH, Ingham HR, Selkon JB.
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():389-93. PubMed ID: 6352650
    [Abstract] [Full Text] [Related]

  • 22. Experience with ceftazidime in cystic fibrosis.
    Dodge J, Zamiri I, Goodchild M, Ingram P.
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():325-9. PubMed ID: 6352637
    [Abstract] [Full Text] [Related]

  • 23. [Cefotaxime in septicaemia and severe infections due to multiresistant Gram-negative bacilli (author's transl)].
    Dureux JB, Canton P, Roche G, Weber M, Gérard A.
    Nouv Presse Med; 1981 Feb 26; 10(8):601-6. PubMed ID: 6259602
    [Abstract] [Full Text] [Related]

  • 24. Ceftazidime - a significant advance in the treatment of cystic fibrosis.
    David TJ, Phillips BM, Connor PJ.
    J Antimicrob Chemother; 1983 Jul 26; 12 Suppl A():337-40. PubMed ID: 6352639
    [Abstract] [Full Text] [Related]

  • 25. Cephacetrile--a new cephalosporin antibiotic.
    Hodson AH, Holloway WJ.
    Int J Clin Pharmacol; 1973 Feb 26; 7(1):89-94. PubMed ID: 4699390
    [No Abstract] [Full Text] [Related]

  • 26. Conditions for the emergence of resistance to cefpirome and ceftazidime in experimental endocarditis due to Pseudomonas aeruginosa.
    Fantin B, Farinotti R, Thabaut A, Carbon C.
    J Antimicrob Chemother; 1994 Mar 26; 33(3):563-9. PubMed ID: 8040120
    [Abstract] [Full Text] [Related]

  • 27. [Clinical studies of ceftazidime in the pediatric field].
    Hoshina H, Mikuni K, Ichihashi H.
    Jpn J Antibiot; 1984 Mar 26; 37(3):460-8. PubMed ID: 6376855
    [Abstract] [Full Text] [Related]

  • 28. A random comparative trial of 0.25, 0.5 and 1.0 g ceftazidime twice daily in urinary tract infection.
    Gentry LO, Douthit MB, Childs SJ, Madsen PO.
    J Antimicrob Chemother; 1983 Jul 26; 12 Suppl A():53-7. PubMed ID: 6352655
    [Abstract] [Full Text] [Related]

  • 29. Clinical evaluation of moxalactam.
    Mathisen GE, Meyer RD, Thompson JM, Finegold SM.
    Antimicrob Agents Chemother; 1982 May 26; 21(5):780-6. PubMed ID: 6213198
    [Abstract] [Full Text] [Related]

  • 30. Clinical evaluation of ceftazidime in Japan.
    Ishibiki K.
    J Antimicrob Chemother; 1983 Jul 26; 12 Suppl A():123-30. PubMed ID: 6225760
    [Abstract] [Full Text] [Related]

  • 31. Ticarcillin for treatment of serious infections with gram-negative bacteria.
    Parry MG, Neu HC.
    J Infect Dis; 1976 Nov 26; 134(5):476-85. PubMed ID: 825582
    [Abstract] [Full Text] [Related]

  • 32. Clinical evaluation of ceftazidime in internal medicine in Japan.
    Shimada K.
    J Antimicrob Chemother; 1983 Jul 26; 12 Suppl A():395-7. PubMed ID: 6225765
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The evaluation of ceftazidime in the treatment of bacterial infections in eighty seriously ill patients.
    Walstad RA, Hellum KB, Svarva PL, Ingram PM.
    J Antimicrob Chemother; 1983 Jul 26; 12 Suppl A():131-7. PubMed ID: 6352614
    [Abstract] [Full Text] [Related]

  • 35. Ceftazidime, as a single antibiotic, in the treatment of multi-resistant Gram-negative infections in intensive care.
    Gasparetto A, Delogu G.
    J Antimicrob Chemother; 1983 Jul 26; 12 Suppl A():171-5. PubMed ID: 6352617
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Reduced sensitivity to beta-lactam antibiotics arising during ceftazidime treatment of Pseudomonas aeruginosa infections.
    King A, Shannon K, Eykyn S, Phillips I.
    J Antimicrob Chemother; 1983 Oct 26; 12(4):363-70. PubMed ID: 6417101
    [Abstract] [Full Text] [Related]

  • 39. Clinical experience with ceftazidime in urology in Japan.
    Kawamura N.
    J Antimicrob Chemother; 1983 Jul 26; 12 Suppl A():65-70. PubMed ID: 6352657
    [Abstract] [Full Text] [Related]

  • 40. [Clinical evaluation of ceftazidime in the field of pediatrics].
    Koshinami M, Watanabe A.
    Jpn J Antibiot; 1984 Mar 26; 37(3):344-8. PubMed ID: 6376847
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.